首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.
【24h】

Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.

机译:钌(II)膦/二亚胺/吡啶甲酸络合物:无机化合物作为抗结核剂。

获取原文
获取原文并翻译 | 示例
           

摘要

This paper describes the synthesis and characterization of four new ruthenium complexes containing 1,4 bis(diphenylphosphino)butane (dppb), 2-pyridinecarboxylic acid anion (pic) and the diimines [(2,2'-bipyridine (bipy), 4,4'-dimethyl-2,2'-bipyridine (Me-bipy), 4,4'-dichloro-2,2'-bipyridine (Cl-bipy) and 1,10-phenanthroline (phen) as ligands, with formulae [Ru(pic)(dppb)(bipy)]PF(6) (SCAR01), [Ru(pic)(dppb)(Me-bipy)]PF(6) (SCAR02), [Ru(pic)(dppb)(Cl-bipy)]PF(6) (SCAR03) and [Ru(pic)(dppb)(phen)]PF(6) (SCAR04). Additionally, the in vitro anti-Mycobacterium tuberculosis (MTB) activity, cytotoxicity and activity against in vitro infection of these complexes and two more complexes, cis-[Ru(pic)(dppe)(2)]PF(6) (SCAR05) and cis-[RuCl(2)(dppb)(bipy)] (SCAR06), and their free ligands are described and discussed. All compounds showed excellent MIC against MTB, low cytotoxicity and a selectivity index higher than 10. Also, all compounds showed significant intracellular inhibition and the compound SCAR05 showed a better activity than rifampin and SQ109. This is the first report of activity against in vitro infection of ruthenium compounds.
机译:本文描述了四种新的钌配合物的合成和表征,这些配合物包含1,4双(二苯基膦基)丁烷(dppb),2-吡啶羧酸阴离子(pic)和二亚胺[(2,2'-bipyridine(bipy),4, 4'-二甲基-2,2'-联吡啶(Me-bipy),4,4'-二氯-2,2'-联吡啶(Cl-bipy)和1,10-菲咯啉(phen)作为配体,其分子式为[ Ru(pic)(dppb)(bipy)] PF(6)(SCAR01),[Ru(pic)(dppb)(Me-bipy)] PF(6)(SCAR02),[Ru(pic)(dppb)( Cl-bipy)] PF(6)(SCAR03)和[Ru(pic)(dppb)(phen)] PF(6)(SCAR04)。此外,体外抗结核分枝杆菌(MTB)活性,细胞毒性和活性对抗这些复合物和另外两种复合物的体外感染:顺式[Ru(pic)(dppe)(2)] PF(6)(SCAR05)和顺式[RuCl(2)(dppb)(bipy)](SCAR06 )及其游离配体的描述和讨论,所有化合物均显示出优异的抗MTB MIC,低细胞毒性和高于10的选择性指数,并且所有化合物均显示出显着的细胞内抑制作用和化合物。 d SCAR05显示出比利福平和SQ109更好的活性。这是关于钌化合物体外感染活性的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号